ArticleInvestigational new drugs2017

Phase 1 study of narnatumab, an anti-RON receptor monoclonal antibody, in patients with advanced solid tumors.

Patricia M LoRusso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.